Summary & Overview
CPT 0483T: Transcatheter Mitral Valve Replacement or Implantation
CPT code 0483T designates a transcatheter mitral valve implantation or replacement—a minimally invasive structural heart intervention in which a prosthetic mitral valve is delivered by catheter through a small skin incision and advanced to the heart to treat mitral valve prolapse or malfunction. The code captures a complex, device-dependent procedure that has national implications for cardiovascular care delivery, hospital resource use, and device coverage policy given its role as an alternative to open surgical valve repair or replacement.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and typical service settings, payer coverage patterns and benchmarks, relevant coding and billing considerations, and recent policy developments that affect authorization, site-of-service decisions, and inpatient vs outpatient classification. The publication also highlights common modifiers and payment nuances associated with advanced cardiac procedures. Where specific data points are not provided in the input, the report notes that those items are not available.
This summary is intended for hospital administrators, clinical coders, reimbursement analysts, and policy stakeholders seeking a national-level briefing on how CPT code 0483T fits into contemporary structural heart care and payer policy.
Billing Code Overview
CPT code 0483T describes a transcatheter mitral valve replacement or implantation procedure. The provider implants a prosthetic mitral valve, or replaces one, by inserting a catheter through a small skin incision and threading it through a vessel to the heart; the provider may or may not puncture the wall between the ventricle and atrium to place the valve. The service is a cardiac interventional procedure performed to treat mitral valve prolapse or malfunction.
Service Type: Transcatheter mitral valve implantation/replacement (structural heart intervention)
Typical Site of Service: Hospital-based cardiac catheterization lab or hybrid operating room; inpatient or selected outpatient settings, depending on patient acuity and institutional protocols.
Clinical & Coding Specifications
Clinical Context
A 78-year-old patient with symptomatic severe mitral regurgitation from degenerative mitral valve prolapse presents with progressive dyspnea on exertion, orthopnea, and reduced exercise tolerance despite optimized medical therapy. The heart team (interventional cardiology and cardiothoracic surgery) evaluates the patient and determines a transcatheter mitral valve replacement is appropriate due to elevated surgical risk. Pre-procedure workup includes transthoracic and transesophageal echocardiography to define valve anatomy, cardiac CT for annular sizing and vascular access planning, coronary angiography as indicated, and routine labs and coagulation studies. On the day of service, the patient is brought to a hybrid operating room or cardiac catheterization laboratory; vascular access (commonly femoral venous and arterial) is obtained, heparin anticoagulation is administered, and transseptal puncture is performed if required to access the mitral valve. Under fluoroscopic and echocardiographic guidance, the operator advances the delivery catheter to the mitral annulus and deploys the prosthetic mitral valve. Hemodynamic assessment and imaging confirm valve position and function; any residual paravalvular leak is assessed and addressed if needed. The patient is monitored in a post-anesthesia care unit or cardiac intensive care unit, with post-procedure echocardiography prior to discharge and instructions for antithrombotic therapy and follow-up with cardiology and heart valve clinic.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |